Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-005469-67Phase 3Completed
Phase 3, randomised, double-blind trial of alclometasone in atopic dermatitis (AD) (2 arms), sponsored by Thornton & Ross. Primary endpoint: Total SCORAD. Started Jan 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-005469-67.